Insider Selling: MeiraGTx Holdings plc (NASDAQ:MGTX) CFO Sells 24,000 Shares of Stock

MeiraGTx Holdings plc (NASDAQ:MGTX) CFO Richard Giroux sold 24,000 shares of the stock in a transaction that occurred on Tuesday, January 21st. The stock was sold at an average price of $6.29, for a total transaction of $150,960.00. Following the transaction, the chief financial officer now directly owns 849,947 shares in the company, valued at approximately $5,346,166.63. This represents a 2.75 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

MeiraGTx Stock Performance

Shares of MGTX stock opened at $6.07 on Friday. The company has a current ratio of 2.34, a quick ratio of 2.34 and a debt-to-equity ratio of 0.86. The company has a market cap of $474.37 million, a PE ratio of -5.02, a P/E/G ratio of 0.35 and a beta of 1.26. The company’s fifty day simple moving average is $6.18 and its 200-day simple moving average is $5.26. MeiraGTx Holdings plc has a 52 week low of $3.85 and a 52 week high of $7.37.

Hedge Funds Weigh In On MeiraGTx

Several hedge funds and other institutional investors have recently made changes to their positions in the business. SG Americas Securities LLC lifted its holdings in shares of MeiraGTx by 13.3% during the 4th quarter. SG Americas Securities LLC now owns 22,240 shares of the company’s stock valued at $135,000 after acquiring an additional 2,617 shares in the last quarter. The Manufacturers Life Insurance Company lifted its holdings in shares of MeiraGTx by 19.0% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 17,763 shares of the company’s stock valued at $75,000 after acquiring an additional 2,839 shares in the last quarter. JPMorgan Chase & Co. lifted its holdings in shares of MeiraGTx by 1.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 342,667 shares of the company’s stock valued at $1,429,000 after acquiring an additional 4,186 shares in the last quarter. Rhumbline Advisers lifted its holdings in shares of MeiraGTx by 10.8% during the 2nd quarter. Rhumbline Advisers now owns 52,996 shares of the company’s stock valued at $223,000 after acquiring an additional 5,178 shares in the last quarter. Finally, State Street Corp lifted its position in shares of MeiraGTx by 0.9% during the third quarter. State Street Corp now owns 574,727 shares of the company’s stock worth $2,397,000 after purchasing an additional 5,251 shares in the last quarter. Institutional investors and hedge funds own 67.48% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on MGTX. Chardan Capital reissued a “buy” rating and set a $36.00 price objective on shares of MeiraGTx in a research note on Monday, November 18th. Royal Bank of Canada boosted their price objective on shares of MeiraGTx from $9.00 to $11.00 and gave the company an “outperform” rating in a research note on Thursday, November 14th.

MeiraGTx Company Profile

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases, neurodegenerative diseases, and xerostomia.